What are the side effects of dacomitinib/dacomitinib?

Dacomitinib/Dacomitinib is a targeted drug, designated epidermal growth factor receptor (EGFR) No. 19exon deletion or 21exonL858R substitution mutation.

Dacomitinib/Common side effects of dacomitinib includediarrhea (87%), rash (69%), < span>Paronychia (64%), Stomatitis (45%), Anemia (44%), Hypoalbuminemia (4 4%), Lymphopenia (42%), Elevated alanine aminotransferase (40%), Hyperglycemia (36%)< /span>, Elevated aminotransferases (35%), Hypocalcemia (33%), Decreased appetite (31%), Dry Skin (30%), Hypokalemia (29%), Weight loss (26%), Hyponatremia (26%), Elevated creatinine (24%), Alopecia (23%), Increased alkaline phosphatase (22%), Hypomagnesemia (22%), Pruritus (21%), Cough (21%), Nasal mucosal disease (19%< span>), nausea (19%), hyperbilirubinemia (16%), palm-plantar paresthesia syndrome (15%), Pain in limbs (14%), Difficulty breathing (13%), Constipation (13%), Asthenia (13%), Oral ulcer ulcer (12%), musculoskeletal pain (12%), upper respiratory tract infection (12% pan>), Dermatitis (11%), Insomnia (11%), Chest pain (< /span>10%), Fatigue (9%), Vomiting (9%), Skin cracks (9%), Gesus disorder (7%), Skin peeling/Exfoliative skin reaction (3.5%), Interstitial lung disease (2.6%), Keratitis accounts for1.8%, hirsutism (1.3%), dehydration (1.3%) etc. If you want to get more high-quality information, you can contact Yaode, and Yaode will do its best to learn more about high-quality overseas drugs for you.